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摘要
目的:评估 SCHWIND AMARIS准分子激光在 LASEK术中
矫治远视手术中的有效性,安全性和可预测性。
方法:回顾性研究 LASEK 术联合使用丝裂霉素 C 矫治远
视患者 33 例 66 眼,平均年龄 35. 42依1. 12 岁 (范围 18 ~
56a)。 每位患者予 SCHWIND AMARIS 准分子激光行
LASEK术。 术后对其可预测性、安全性、有效性及主观验
光情况进行评估,并分析客观验光、裸眼视力、最佳矫正视
力及不良反应。
结果:平均屈光度为 3. 2依1. 6D(0 ~ 7D),术前及术后平均
等效球镜分别为 2. 34 依 1. 76D ( - 1. 25 ~ 7D)及 0. 30 依
0郾 84D(-0. 2 ~ 0. 8D)(P=0. 001)。 术后 6 ~ 12mo,平均远
视为 0. 63依0. 84D(-1. 75 ~ 2. 76D)。 平均散光度为 0. 68
依0. 43D(0 ~ 2D),61 眼(78. 2% )和 31 眼(39. 7% )散光度
分别在依1D和依0. 50D范围内。 安全指数和有效性指数分
别为 1. 08 和 1. 6。
结论:应用 SCHWIND AMARIS 准分子激光联合丝裂霉素
C行 LASEK术矫治远视具有良好的视觉和屈光结果,而
且无严重并发症。
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Abstract
誗AIM: To evaluate the efficacy, safety and predictability
of laser-assisted sub-epithelial keratectomy (LASEK) for
the correction of hyperopia using the SCHWIND AMARIS
platform.
誗 METHODS: This retrospective single - surgeon study
includes 66 eyes of 33 patients with hyperopia who
underwent LASEK with mitomycin C (MMC) . The median
age of patients was 35. 42依1. 12y ( ranging 18 to 56y) . In
each patient LASEK was performed using SCHWIND
AMARIS excimer laser. Postoperatively clinical outcomes
were evaluated in terms of predictability, safety, efficacy,
subjective and objective refractions, uncorrected visual
acuity (UCVA), best spectacle - corrected visual acuity
(BSCVA) and adverse events.
誗RESULTS: The mean baseline refraction was 3. 2 依 1. 6
diopters (D) (ranging 0 to 7 D) . The mean pre-operative
and postoperative spherical equivalent (SE) were 2. 34 依
1郾 76 (ranging -1. 25 to 7 D) and 0. 30依0. 84 ( ranging -0. 2
to 0. 8 D) respectively (P = 0. 001) . The mean hyperopia
was 0. 63 依 0. 84 D ( ranging - 1. 75 to 2. 76 D) 6 to 12mo
postoperatively. Likewise, the mean astigmatism was
0郾 68依 0. 43 D ( range 0 to 2 D) with 51 (77. 3%) and 15
(22郾 7%) eyes within 依 1 and 依 0. 50 D respectively. The
safety index and efficacy index were 1. 08 and 1. 6
respectively.
誗 CONCLUSION: LASEK using SCHWIND AMARIS with
MMC yields good visual and refractive results for
hyperopia. Moreover, there were no serious complications.
誗KEYWORDS:LASEK;SCHWIND AMARIS;mitomycin C;
hyperopia
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INTRODUCTION
T he development of excimer laser technology over the past2 decades has portended a new phase in refractive
surgery. Since 1983, when the modern period of refractive
surgery began with the experimental introduction of the 193nm
argon fluoride excimer laser by Trokel et al[1], refractive
surgery has been widely used because of its precise
predictability and safety in treating low to moderate myopia[2] .
Photorefractive keratectomy ( PRK ) first used in human
corneas in 1987 by McDonald et al[3] . In the early 1990s,
The automated micro-keratome was modified and incorporated
into laser in situ keratomileusis ( LASIK) [4,5] . Since then,
LASIK has become the most popular refractive procedure in
the world and was considered by many experts to be the
refractive procedure of choice. In 1999, laser-assisted sub-
epithelial keratomileusis ( LASEK ) was introduced by
Camellin[6] . This technique has become popular for correcting
refractive errors ( RE), particularly in cases with moderate
degrees of myopia, suggesting that the refractive and visual
outcomes in LASEK patients were better than conventional
PRK[7,8] .
Epithelial flap in Camellin蒺s LASEK technique is detached
after application of an alcohol solution and repositioned as in
the LASIK procedure following laser ablation. The epithelium
regenerates in a few days;during this time the flap protects the
ablated stromal surface. Mitomycin C (MMC) is an alkylating
agent with cytotoxic and anti-proliferative effects. It is used
as prophylactic to keep away from haze after primary surface
ablation and for modulation of corneal wound healing[9] .
Although results for hyperopic corrections have been
encouraging, the surgical correction of hyperopia remains a
challenge in spite of the development of numerous
technologies. Surface ablation for the correction of hyperopia
is documented with poor predictability, slower visual recovery
and refractive stability compared to myopic treatments[10-13] .
To our knowledge there are few investigations related to
hyperopic LASEK using MMC[13] . To address this issue and
evaluate the safety and efficacy of LASEK for hyperopia using
MMC, we conducted this retrospective study.
SUBJECTS AND METHODS
Patients蒺 Number and Assessment摇 This retrospective study
comprised 66 eyes of 33 patients who had LASEK for
hyperopia, performed with the AMARIS excimer laser
(SCHWIND eye-tech-solutions, Kleinostheim, Germany).
The Institutional Review Board of the Eye Research Center,
Bina Eye Hospital approved this study and followed the tenets
of the Declaration of Helsinki. Exclusion criteria were:
corneal or retinal disease, previous eye surgery, collagen
vascular disease, keratoconus, glaucoma, cataract, pregnancy
and current systematic corticosteroid therapy. Hard contact
lenses were discontinued 3wk and soft contact lenses 2wk
before the final measurement and surgery. The preoperative
examination included measurement of uncorrected visual
acuity ( UCVA ), best spectacle - corrected visual acuity
(BSCVA), manifest and cycloplegic refractions;slit-lamp bio-
microscopy;fundus evaluation; and corneal topography. The
goal of all surgeries was emmetropia. Patients were followed
for 6 to 12mo postoperatively. The nature of the procedures
and its related benefits and risks were explained precisely to
all patients.
Operative Procedure 摇 The procedures were performed by
the same surgeon ( Jadidi K) under sterile conditions and
topical anesthesia ( proparacain hydrochloride 0. 5% ).
Twenty percent alcohol was applied to the center of the cornea
for 15s using a corneal well. It was then thoroughly rinsed
with a balanced salt solution. A 9 mm epithelial trephine
( Shahinian LASEK trephine;Katena Products Inc. , Denville,
NJ, USA) was used to create a 270毅 epithelial hinge. The
epithelial flap was reflected back from the cornea with an
epithelial peeler ( hack knife and vok cell Sloane LASEK
Micro Hoe;Katena Products Inc. ) . Excimer laser treatment
was performed using the nomogram. The optical zone varied
between 6 mm and 7 mm, and transition zone was calculated
based on the patient蒺s age, RE, and K readings by means of
the nomogram. Following ablation, with regard to the
refraction number of each patient, a cellulose surgical spear
soaked in 0. 02% MMC was applied to the ablated area. The
duration of MMC application was 30s. The epithelial flap was
rinsed with a balanced salt solution before being repositioned
with the edges overlapping the original intact epithelium. A
new bandage contact lens ( BCL ) was placed after laser
ablation on the cornea and one drop each of a topical
antibiotic agent and steroidal agent was given. Postoperatively
patients were given bethamethasone drops 4 times a day,
chloramphenicole drops 4 times a day, and preservative-free
artificial tears every 2h. Chloramphenicol drops was
discontinued 1wk postoperatively but betamethasone drops
tapered off during 4 -6wk. Moreover, there were no serious
complications except low grade corneal haze.
Safety, Efficacy and Predictability 摇 The safety of the
procedure was defined as the percentage of eyes losing more
than 2 lines of Snellen BSCVA. Safety index is equal to the
ratio ( mean postoperative BSCVA / mean preoperative
BSCVA). The efficacy was defined as the percentage of the
eyes, achieving a UCVA of 0. 5 ( 20 / 40 ) or better
postoperatively. The efficacy index is equal to the ratio (mean
postoperative UCVA / mean preoperative BSCVA) [14,15] . The
predictability of refractive SE was the percentage of eyes with
依 1 D and 依 0. 50 D of emmetropia at 6 to 12mo
postoperatively[16] .
Statistical Analysis 摇 All visual acuity measurements were
converted from Snellen to logarithm of the minimum angel of
resolution ( logMAR ). All continuous variables were
expressed as mean ( SD), correspondingly for non - normal
data were expressed as median ( IQ). Paired student t-test
and colmogrov - smirnov test were used to compare
ophthalmologic changes pre and post operatively for normal
and non-normal continuous variables, respectively. P<0. 05
were considered statistically significant. All analyzes were
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摇 摇 摇 摇 摇 摇 摇 摇 摇 摇 摇 Table 1摇 Mean preoperative and postoperative visual and refractive outcomes
摇 摇 摇 摇 摇 摇 摇 摇 摇 摇 摇 摇 during 6-12mo follow-up period
Parameters Before surgery 6 to 12mo after surgery P
BCVA (logMAR) 0. 06依0. 13 0. 05依0. 10 0. 804
Refractiveerror (D) 3. 2依1. 6 0. 6依0. 8 <0. 001
Astigmatism (D) -1. 8依1. 7 -0. 7依0. 4 <0. 001
SE 2. 3依1. 8 0. 3依0. 8 <0. 001
摇 摇 摇 摇 摇 摇 摇 摇 摇 摇 摇 摇 BSCVA: Best spectacle-corrected visual acuity;SE: Spherical equivalent. P<0. 05
摇 摇 摇 摇 摇 摇 摇 摇 摇 摇 摇 摇 demonstrate significancy.
performed using SPSS version 18 software ( SPSS Inc. ,
Chicago, IL, USA)
RESULTS
In this study of 33 patients, 15(45. 5% ) were males and 18
(54. 5) % were females. The mean age at the time of the
surgical intervention was 35. 9 依 10. 7y ( from 18 to 56 ).
Preoperative mean RE was 3. 2 依1. 6 diopters (D) (range: 0
to +7. 00 D), whereas 6 to 12mo postoperatively the mean RE
was 0. 6 依0. 8 D ( range: -1. 75 to 2. 76 D). A significant
reduction was reported between the preoperative and 1 -year
postoperative mean RE (P <0. 001) ( Table 1) . The mean
preoperative and postoperative spherical equivalent (SE) were
2. 34依1. 76 (range-1. 25 to 7 D) and 0. 30依0. 84 ( range -
0. 2 to 0. 8 D) respectively (P = 0. 001). At 6 to 12mo, 43
(65. 2% ) eyes were within 依 1. 00 D of the intended
correction RE and 23 (34. 8% ) eyes were within 依0. 50 D.
Preoperative and 6 to 12mo postoperative mean astigmatism
were -1. 8依1. 7 (range: 0 to 5. 50) and -0. 7依0. 4 ( range:
0 to 2), respectively. These results indicated a significant
reduction (P<0. 001). At 6 to 12mo, 51 (77. 3% ) eyes
were within 依1. 00 D of the intended correction astigmatism
and 15 ( 22. 7% ) eyes were within 依 0. 50 D. Mean
preoperative BSCVA was 0. 06 依0. 13 logMAR ( range: 0 to
0郾 70 logMAR) and mean 6 to 12mo postoperative BSCVA was
0. 05依0. 1 logMAR (range: 0 to 0. 39 logMAR). There was
no significant difference between mean pre-operative and 6 to
12mo postoperative BSCVA (P < 0. 804). The safety index
and efficacy index were 1. 08 and 1. 6 respectively.
Additionally, at the six-month follow-up and thereafter, two
eyes gained four lines of BSCVA, 13 gained one line and 44
eyes showed no change. Three eyes lost one line of Snellen
decimal equivalent BSCVA and four eyes lost more than one
line (Figure 1) . Corneal haze was detected in just about 5%
of our study cases that was not so serious to affect visual acuity
(data not shown).
DISCUSSION
LASIK for correcting hyperopia proved to be more challenging
than correcting myopia primarily because the excimer lasers
have to be capable of delivering peripheral laser pulses to
flatten the peripheral cornea for steepening the central cornea.
Secondarily, larger diameter flaps should be produced by a
new generation of microkeratomes. Moreover, studies of
hyperopic PRK and hyperopic LASIK have demonstrated
acceptable efficacy for corrections up to 4. 00 D, but with
Figure 1 摇 Percentages of eyes with BSCVA gain and loss 6 -
12mo after surgery.
limited predictability for higher-order corrections[10-12] .
Alternatively, nowadays there are several laser systems
capable of hyperopic ablations and various microkeratomes
competent of creating large - diameter flaps. The AMARIS
excimer laser technology is based on a new ablation patterns
incorporating a six-dimensional eye-tracking subsystem which
tracks not only pupil movements, but also rolling movements
of the eye, as well as torsional movements and movements
along the propagation axis of the laser. This pattern minimizes
the induction of aberrations that will allow us to perform
LASEK more predictably and safely[17,18] . Additionally,
recent studies proposed LASEK to be superior refractive
procedure compared with PRK and LASIK due to the
possibility of larger diameter optical zone, a reduction in
pain, faster visual rehabilitation, better visual acuity,
decreased corneal haze, ability to treat thinner corneas and
absence of stromal flap problems in LASEK - treated
patients[19-27] .
In this retrospective study, we assessed efficacy, safety and
stability of hyperopic LASEK with MMC. The safety of the
procedure was defined as the percentage of eyes losing more
than 2 lines of Snellen BSCVA. We found that 6% of eyes
lost 2 or more lines of BSCVA, indicating a reasonable level
of safety. In addition, the efficacy and safety index were more
than 1. 00 at 6 to 12mo postoperatively that showed the visual
outcomes were satisfactory.
In a prospective pilot study by O蒺Brart et al[28] ( 2007 )
comprised 45 patients ( 68 eyes ), treated with LASEK,
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preoperative mean SE was +2. 19 D, ranging from 0 to +4郾 25 D,
while mean pre - operative cylinder was - 0. 79 D, ranging
from 0 to - 5. 0 D. Patients underwent LASEK with a
SCHWIND ESIRIS excimer laser with a large optical zone of
7. 0 mm and a 1. 0 mm transition zone in every case. At the 6
to 12mo follow - up visits, 98% of eyes were within one
dioptre of the intended correction, while 88% were within
0郾 5D. At the six-month follow-up and thereafter, two eyes
gained two lines of BSCVA, 11 gained one line and 28 eyes
showed no change. Two eyes lost one line of Snellen decimal
equivalent BSCVA. No eyes lost more than one line. Analysis
of complications showed no axial corneal haze in any eyes,
with a peripheral ring of faint haze 7. 0 mm in diameter in
seven percent of eyes after between six and 12mo follow-up.
In our study, patients underwent LASEK with a SCHWIND
AMARIS excimer laser. The optical zone and transition zone
were 6. 6 mm and 1. 6 mm respectively. When comparing our
results with those of O蒺Brart et al[28] ( 2007 ), they were
similar regarding the mean reduction of the K average value.
However, when we further analyzed this amount of reduction
in relation to the initial preoperative values, we observed a
positive significant correlation;that is, the higher the optical
zone, the better outcome achieved after surgery. Moreover, in
our study that were categorized based on ages and transition
zone on outcome (data not shown), we revealed statistically
significant difference between two groups in term of transition
zone (P = 0. 004), but no significant difference in term of
ages was found (P=0. 576). Interestingly in O蒺Brart et al[28]
study, transitional zone was lower than our study (1mm versus
1. 6 mm). We speculate that transitional zone may have a
prominent role in outcome that should not be overlooked in
future studies.
O蒺Brart et al[29] theorized that improved outcomes with the
SCHWIND ESIRIS laser might be due to the large diameter
optical zone and the smoother ablation profile achievable with
scanning spot technology. He showed that hyperopic LASEK
with the ESIRIS laser results appear to be very favorable
compared to published outcomes with LASIK and PRK.
LASEK with large diameter optical zone treatments (7. 0 mm
or greater) achieves very favorable outcomes for the correction
of hyperopia up to +4. 5 D hyperopia[30] .
In this study, we demonstrated the reason of rather
discouraging excimer laser hyperopic treatments in the past
were due to too small optical zones;the optical zone was 6. 6
mm and it was slightly smaller than O蒺Brart et al[28] study,
whereas the transitional zone was larger (1. 6 mm). Actually,
the use of small optical zones will have a greater propensity to
the induction of higher-order aberrations, especially as many
hyperopes have a large angle kappa often requiring the
treatment to be de-centered from the entrance pupil centre,
which can result in a significant loss of postoperative visual
performance, especially as ( unlike myopic treatments) there
are no benefits from postoperative retinal magnification. In
addition, in myopic treatments we know that the large optical
zone corrections (6. 0 mm or greater) are more predictable,
safer and more stable than smaller diameter (5. 0 mm or less)
treatments. Therefore, knowing the facts mentioned above, to
some extend may explain our results.
Also, de Ortueta et al[31] found a good predictability after H-
LASIK with the ESIRIS system, with 92 % of the eyes having
a postoperative refraction within 依 0. 50 D of the attempted
correction. We demonstrated a refractive outcome within 依1. 00 D
of emmetropia in 78. 2% of eyes in the present study with
AMARIS system. Thus in comparison to previous
studies[28-31], there is slightly difference in terms of intended
correction which could be explained by differences in optical
zone and transitional zone. Likewise, we agree with O蒺Brart et
al[28] theory, better outcomes in terms of predictability and
visual performances are closely related to larger optical zone.
Furthermore, we found that regression of initial effect was
more stable than previous studies and no re-treatments were
performed in the 6 to 12mo of follow - up due to under -
correction or hyperopic regression, possibly because there was
less stimulation of sub - epithelial connective tissue with
LASEK.
In conclusion, we have shown - LASEK using SCHWIND
AMARIS yields very satisfactory visual outcomes for hyperopia
and hyperopic astigmatism. In addition, there were no sight-
threatening complications. Further studies with a longer
follow - up period and a larger number of patients are
recommended to draw final conclusions about the efficiency
and safety of LASEK using SCHWIND AMARIS. Ths study is
underway, and the results will be reported soon.
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